24/7 Market News Snapshot 22 September, 2025 – Qualigen Therapeutics, Inc. Common Stock (NASDAQ:QLGN)
DENVER, Colo., 22 September, 2025 (www.247marketnews.com) – (NASDAQ:QLGN) are discussed in this article.
Qualigen Therapeutics, Inc. has experienced a remarkable increase in its stock, with pre-market trading reflecting a surge to $8.297, marking a 192.15% rise from the previous day’s close of $2.840. The trading volume reached 2.26 million shares, indicating heightened investor interest and confidence in the company’s innovative therapeutic solutions. This surge is positioned against the backdrop of a significant strategic investment from Faraday Future Intelligent Electric Inc., amounting to approximately $30 million. Announced during Qualigen’s annual event, this investment signifies a pivotal moment for the company as it transitions to the CXC10 brand, which will focus on substantial advancements in the crypto and Web3 ecosystems.
Faraday Future’s Founder and Co-CEO, YT Jia, plans to further invest $4 million through a loan, reinforcing his role as a key investor with a two-year lockup on his shares. This partnership is poised to enhance Qualigen’s financial stability and support its ambitious “Dual-Flywheel & Dual-Bridge” Eco Strategy, aimed at maximizing shareholder value through innovative product exploration.
CXC10 intends to bridge traditional Web2 services with the emerging Web3 market by concentrating on three primary growth engines: the C10 Treasury and Index as a value anchor, the BesTrade DeAI Agent as an AI-driven trading assistant, and ecosystem tokens designed for value creation. The company aims to launch six significant products within this framework.
Additionally, the C10 Treasury has shown an impressive unrealized gain of 7% as of mid-September, surpassing the broader C10 index. Qualigen’s recent annual event also showcased cutting-edge technology, including a dual-screen panoramic display for its FX Super One MPV, representing a new benchmark in the driving experience. With these developments, Qualigen is strategically positioned to capitalize on emerging market opportunities, solidifying its role as a disruptive force in the AI, crypto, and automotive sectors.
Related news for (QLGN)
- Univest Securities, LLC Announces Closing of $41 Million Strategic Investment in Client Qualigen Therapeutics (NASDAQ: QLGN) from Client Faraday Future (NASDAQ: FFAI)
- 24/7 Market News Snapshot 30 September, 2025 – Qualigen Therapeutics, Inc. Common Stock (NASDAQ:QLGN)
- Qualigen Therapeutics Announces Successful Closing of $41 Million PIPE Financing Led by Faraday Future, Accelerating New Business Transformation into Crypto
- Faraday Future Announces Closing of Strategic $41 Million Investment in Qualigen Therapeutics (NASDAQ: QLGN) to Accelerate its Dual-Flywheel & Dual-Bridge Eco Strategy
- 24/7 Market News Snapshot 30 September, 2025 – Qualigen Therapeutics, Inc. Common Stock (NASDAQ:QLGN)